Hims & Hers Health is a telehealth company that provides consumers with access to healthcare services online. The announcement that they will be offering compounded GLP-1 (glucagon-like peptide-1) injections suggests that they are expanding their product offerings to include treatments for conditions like diabetes and obesity.
GLP-1 is a hormone that stimulates the release of insulin, the hormone responsible for regulating blood sugar levels. Injections of a synthetic version of this hormone can help individuals who aren’t producing enough insulin naturally. These injections are often prescribed to people with type 2 diabetes, along with lifestyle changes and other medications, to help manage their condition.
Compounded medications are not the same as typical prescribed drugs. They are custom-made by a pharmacist to meet a patient’s specific needs. Factors like dosage form, strength, flavor, or even the exclusion of potential allergenic ingredients can be customized in compounded medications.
While this move is likely to provide more options for those seeking treatment through online healthcare providers, it’s always critical for patients to consult with their healthcare provider before beginning any new treatment plan.
